IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,432 | -40.8% | 11,200 | -38.1% | 0.00% | 0.0% |
| Q4 2022 | $115,659 | -53.9% | 18,100 | -30.9% | 0.00% | -66.7% |
| Q3 2022 | $250,996 | +0.4% | 26,200 | +231.6% | 0.00% | +50.0% |
| Q1 2021 | $250,000 | -43.8% | 7,900 | -17.7% | 0.00% | -60.0% |
| Q4 2020 | $445,000 | +46.9% | 9,600 | +4.3% | 0.01% | +66.7% |
| Q3 2020 | $303,000 | -40.9% | 9,200 | -50.8% | 0.00% | -50.0% |
| Q2 2020 | $513,000 | -16.9% | 18,700 | -9.2% | 0.01% | -25.0% |
| Q1 2020 | $617,000 | +9.8% | 20,600 | +1.5% | 0.01% | +33.3% |
| Q4 2019 | $562,000 | – | 20,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |